Presentations & Press
The laboratory is playing an active role in the outreach events disseminating our discoveries through press and public presentations. Here are some examples of these activities and events.
2026
June 17, 2026 | Miller School of Medicine News
From Diagnosis to Discovery: One Family, a Scientific Community and a Search for Answers for a Rare Disease – Dr. Kirill Martemyanov and his research team joined families, clinicians, and researchers from around the world at the June 19–20 GNAO1 meeting in Orlando to share scientific advances and connect with the patient community. Read more
June 06, 2026 | Miller School of Medicine
Could Blocking A Brain Receptor Help Treat Depression? – In a recent episode of Inside UMiami Medicine, Dean Henri Ford interviews Dr. Kirill Martemyanov to explore a receptor that may hold the key to developing new treatments for major depressive disorder. Tune in here
February 05, 2026 | Miller School of Medicine Physician Blog
Nanobody-Based Immunotherapy: A Potential Solution for Major Depressive Disorders? Read more
2022
October 28, 2022 | UF Scripps Campus News, Vol. 10
Invention of the Year: A Strategy to Enhance the Safety of Opioid Pain Relievers. Read more
2021
“The Science of Sight: An Eye-Opening Presentation on the Neuroscience of Vision”
February 17, 2021 | The Front Row Lecture Series at Scripps
2020
October 1, 2020 | TSRI News Release
Why do people respond differently to the same drug?
A sweeping study of proteins that modulate cell signaling could lead to a better understanding of myriad diseases—and of what makes us all different. To read the study that inspired the press release, click “download” below.
September 2, 2020 | TSRI News Release
Wiring the eyes to the brain for color vision
Color-discriminating cone cells in the retina use a pair of “adhesion” proteins to connect to the brain. To read the study that inspired the press release, click “download” below.
2019
August 16, 2019 | TSRI News Release
Also seen in: ScienceDaily (August 16, 2019) and BioSpace (August 19, 2019)
Discovery of anti-opiod pathway offers new route to designing safer pain medications
Design and implementation of a new, unbiased approach for decoding the genetic network that controls actions of opioids in a nervous system. To read the study that inspired the press release, click “download” below.
2018
Dr. Laurie Sutton of the Martemyanov Lab explains the neuroscience of depression:
June 2018 | WPTV’s To The Point | click image to view recording.
2017
December 2017 | TSRI News and Views
To forget or to remember? Memory depends on subtle brain signals, scientists find
Understanding how brains actively erase memories, which may open new understanding of memory loss and aging as well as the possibility for new treatments for neurodegenerative disease. To read the study that inspired the story, click “download” below.
March 2017 | TSRI News and Views
Fighting blindness: scientists bring a key protein into focus
Discovering how a protein called α2δ4 establishes proper vision helps explain why mutations in the gene encoding α2δ4 lead to retinal dystrophy, a disease characterized by defective color vision and night blindness. To read the study that inspired the story, click “download” below.
The-Auxiliary-Calcium-Channel-Subunit-a2d4-Is-Required-for-Axonal-Elaboration-Synaptic-Transmission-and-Wiring-of-Rod-PhotoreceptorsDownload
2016
October 28, 2016 | Medical News Today
Also seen in: Medical Xpress (October 27, 2016)
Scientists illuminate key molecular player in both morphine addiction and rare disease
Protein neurofibromin 1 (NF1) influences opioid response through its impact on a signaling protein known as Ras, in a part of the brain called the striatum that is involved in decision-making and reward. To read the study that inspired the story, click “download” below.
2015
September 28, 2015 | The Scripps Research Institute – News and Views
Also seen in: Eureka Alert (September 22, 2015) and Medical Xpress (September 22, 2015)
Scientists identify a key morphine regulator that may reduce risk of pain-killer abuse and addiction
A specific molecule controls morphine receptor signaling in a small group of brain cells, giving insight into a new drug target for developing less-addictive pain medications – and even offering a clue to the genetic predisposition of patients to addiction before treatment. To read the study that inspired the story, click “download” below.
Regulator-of-G-Protein-Signaling-7-Regulates-Reward-Behavior-by-Controlling-Opioid-Signaling-in-the-Striatum-1Download
2014
April 23, 2014 | The Scripps Research Institute – News and Views
Also seen in: Newswise (April 22, 2014) and HealthCanal (April 22, 2014)
Dr. Kirill Martemyanov and researchers in his lab identify critical new protein complex involved in learning and memory
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have identified a protein complex that plays a critical but previously unknown role in learning and memory formation. To read the study that inspired the story, click “download” below.
RGS7Gβ5R7BP-Complex-Regulates-Synaptic-Plasticity-and-Memory-by-Modulating-Hippocampal-GABABR-GIRK-SignalingDownload
2013
November 11, 2013 | The Scripps Research Institute – Etcetera
Dr. Kirill Martemyanov receives ARVO Achievement Award (Cogan Award for Opthamology Research)
Kirill Martemyanov has won the Cogan Award from the Association for Research in Vision and Ophthalmology (ARVO), a widely respected international eye and vision research organization with nearly 13,000 members worldwide. The award recognizes promising young researchers whose important and worthwhile contributions to ophthalmology research are directly related to disorders of the human eye or visual system. To read the award dedication given in May of 2014, click “download” below.
2012
June 25, 2012 | The Scripps Research Institute – News and Views
Also seen in: Scicasts (June 11, 2012) and Medical Xpress (June 11, 2012)
Dr. Kirill Martemyanov and postdoctoral fellow, Yan Cao, discover molecules important for vision and brain function
Several proteins are identified that help regulate cells’ response to light—and the development of night blindness, a rare disease that abolishes the ability to see in dim light. To read the study that inspired the story, click “download” below.
Regulators-of-G-Protein-Signaling-RGS7-and-RGS11-Determine-the-Onset-of-the-Light-Response-in-ON-Bipolar-NeuronsDownload